CD4 and COVID-19: Given that all of the uninfected and the majority (87.5%) of the post-COVID-19 individuals were vaccinated with the BNT vaccine, an mRNA-based vaccine that encodes for the full length spike protein [42], our data indicated that the vaccine could robustly induce CD4+ and CD8+ responses against spike.